Werewolf Therapeutics, Inc. HOWL NASDAQ

Werewolf Therapeutics, Inc. (HOWL) reported total assets of $69.4M and total liabilities of $44.59M for quarter ending 2025-12-31, resulting in total equity of $24.81M.

The company held $57.05M in cash and short-term investments. Total debt stood at $37.67M, with net debt of $-19.38M. The Debt-to-Equity (D/E) ratio was 1.52 (leveraged).

Current ratio is 1.62, indicating strong short-term liquidity. Interest coverage is -6.9x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (0/100) — Total assets $69.4M and equity $24.81M support the company's competitive scale
• VALUE (60/100) — Debt-to-Equity 1.52 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 37/100 with 2/7 criteria passed.